In the ever-evolving field of epilepsy, a true pioneer stands out: Michael Sperling, MD, whose impact on the specialty has been nothing short of remarkable. But what sets him apart in this dynamic landscape? It's the unwavering dedication to advancing epilepsy research and care, earning him the prestigious AES Lifetime Achievement Award.
Dr. Sperling, the Baldwin Keyes Professor of Neurology and vice chair for research at the Sidney Kimmel Medical College, has been a beacon of knowledge and innovation. His contributions are vast, from founding and directing the Jefferson Comprehensive Epilepsy Center to becoming an internationally acclaimed clinician-scientist. With over 500 peer-reviewed papers published, his influence is undeniable. And the accolades don't stop there—he's also a recipient of the J. Kiffin Penry Award (2018) and the Ambassador for Epilepsy Award (2021).
At the 2025 American Epilepsy Society (AES) Annual Meeting, Dr. Sperling was honored with the Lifetime Achievement Award, recognizing his profound impact on both the clinical and scientific aspects of epilepsy. In an interview with NeurologyLive®, he reflected on this achievement and the journey that led him there, acknowledging the pivotal role of his colleagues and mentors.
But here's where it gets controversial... Dr. Sperling believes the field must shift its focus. While seizures are a central concern, he argues that other aspects, like intractable spikes, especially in children, deserve more attention. These spikes disrupt brain processing and memory consolidation, and he advocates for a holistic approach that addresses these disturbances to reduce comorbidities. He also highlights the need to explore personalized treatment strategies and redesign clinical trials to accommodate various epilepsy types and severities.
When asked about his optimism for epilepsy patients, Dr. Sperling reveals a promising future. He discusses new therapeutic and diagnostic approaches, including groundbreaking seizure detection tools and monitoring techniques. He emphasizes the potential of predicting seizures, which could revolutionize epilepsy management. Moreover, he points to the explosion of genetics discoveries and the expanding pipeline of drugs, offering hope for more effective treatments.
And this is the part most people miss... Dr. Sperling believes the key to progress lies in collaboration. He stresses the importance of working together to drive innovation, citing his experience as Editor in Chief of Epilepsia, where he witnessed the power of national and international collaborations. He encourages fostering these partnerships to generate diverse ideas and insights, leading to more generalizable data that benefits everyone in the field.
The interview concludes with a call to action for the epilepsy community to focus on prevention and the development of predictive biomarkers. Dr. Sperling's vision is clear: epilepsy management must be collaborative, embracing diverse perspectives to tackle the complex challenges this specialty presents. His insights offer a compelling roadmap for the future of epilepsy care, leaving readers with a sense of hope and a renewed appreciation for the power of collective effort.
